Hilde Vermeirsch
Research Subjects
Hilde Vermeirsch has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Theo F. Meert
3 shared publicationsPhilip L. Salmon
2 shared publicationsRia Biermans
1 shared publicationRony M. Nuydens
1 shared publication
Latest Publications
- 1 August 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 87 (3) , 349-359
Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat
- 1 August 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 87 (3) , 349-359
Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat
- 1 October 2004
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 79 (2) , 243-251
Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity
- 1 October 2004
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 79 (2) , 243-251
Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity
- 27 January 2004
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 94 (2) , 59-64
Morphine‐Induced Analgesia in the Hot‐Plate Test: Comparison between NMRInu/nu and NMRI mice
NMRInu/nu mice are frequently used in cancer research, but their use in behavioural pain tests is unexplored. As behaviour of NMRI mice in pain tests is well‐documented, a hot‐plate test was performed comparing acute thermal nociception in NMRInu/nu and NMRI mice – untreated and morphine‐treated – to estimate the usefulness of NMRInu/nu mice for further research on cancer pain. In both strains, morphine dose‐dependently increased response latencies, number of animals reaching cut‐off times and AUC values. Yet in NMRInu/nu mice, as compared to NMRI mice, all curves were shifted to the right. In order to be comparable, cut‐off times must express a similar degree of baseline response augmentations. NMRInu/nu mice had substantially lower pre‐drug latencies, indicating a lowered threshold for painful thermal stimuli, therefore effects of morphine in NMRInu/nu mice were also analysed using a lower cut‐off time. Doing so, morphine resulted in similar effects in both strains. The effects were independent of hot‐plate temperature, because similar results were obtained using temperatures of 50 and 55 °. The different morphine sensitivity of NMRInu/nu compared to NMRI mice primarily seems to depend upon differences in thermal threshold, probably induced by the different genotype of both strains. To determine whether cancer alters pain threshold or morphine analgesia, LoVo tumour‐bearing NMRInu/nu mice were also tested. The tumour presence had no influence on withdrawal latencies or morphine efficacy. In general it can be concluded that NMRInu/nu mice with or without tumour can be used for nociceptive testing if baseline sensitivity is properly defined.
- 27 January 2004
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 94 (2) , 59-64
Morphine‐Induced Analgesia in the Hot‐Plate Test: Comparison between NMRInu/nu and NMRI mice
NMRInu/nu mice are frequently used in cancer research, but their use in behavioural pain tests is unexplored. As behaviour of NMRI mice in pain tests is well‐documented, a hot‐plate test was performed comparing acute thermal nociception in NMRInu/nu and NMRI mice – untreated and morphine‐treated – to estimate the usefulness of NMRInu/nu mice for further research on cancer pain. In both strains, morphine dose‐dependently increased response latencies, number of animals reaching cut‐off times and AUC values. Yet in NMRInu/nu mice, as compared to NMRI mice, all curves were shifted to the right. In order to be comparable, cut‐off times must express a similar degree of baseline response augmentations. NMRInu/nu mice had substantially lower pre‐drug latencies, indicating a lowered threshold for painful thermal stimuli, therefore effects of morphine in NMRInu/nu mice were also analysed using a lower cut‐off time. Doing so, morphine resulted in similar effects in both strains. The effects were independent of hot‐plate temperature, because similar results were obtained using temperatures of 50 and 55 °. The different morphine sensitivity of NMRInu/nu compared to NMRI mice primarily seems to depend upon differences in thermal threshold, probably induced by the different genotype of both strains. To determine whether cancer alters pain threshold or morphine analgesia, LoVo tumour‐bearing NMRInu/nu mice were also tested. The tumour presence had no influence on withdrawal latencies or morphine efficacy. In general it can be concluded that NMRInu/nu mice with or without tumour can be used for nociceptive testing if baseline sensitivity is properly defined.